BBR®: Clinically Studied Postbiotic for Healthy Cholesterol Support

BBR® is a heat-killed postbiotic preparation of Bifidobacterium breve IDCC 4401 developed by Ildong Bioscience for healthy cholesterol support.

In a randomized, double-blind, placebo-controlled clinical trial, BBR® demonstrated significant benefits in key markers of cholesterol health, with effects observed as early as Week 4 and maintained throughout the 12-week study.

Mechanistic research suggests that BBR® may physically bind cholesterol and bile acids in the intestine, helping limit reabsorption and promote excretion. Its cholesterol-binding functionality is retained after heat treatment.

With a 24-month shelf life, broad formulation flexibility, Self-Affirmed GRAS status, Health Canada licensing, Korean regulatory recognition and patent protection, BBR® offers brands a differentiated, science-backed postbiotic for cardiovascular health.